Skip to main content
    G

    Grace Therapeutics, Inc. (GRCE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.72
    -0.03 (-1.71%)

    Market Cap: $36.81M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Grace Therapeutics, Inc. (GRCE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Grace Therapeutics (GRCE) has a latest price of $1.72 on Nov 17, 2026, 66.8% below its 52-week high of $5.18. Its price fell 43.8% over the past 12 months.

    Price Chart

    From Oct 2024 to Oct 2026, its highest month-end close was $4.63 in Mar 2026 and its lowest $1.94 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GRCE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GRCE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 21.8%, and over 6 months it fell 20.0%.

    PeriodChange
    1 month-8.5%
    3 months-21.8%
    6 months-20.0%
    12 months-43.8%
    12 months, with dividends-43.8%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$1.94-43.9%
    2025$3.46-7.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 13.8% below its 50-day average of $1.99 and 36.4% below its 200-day average of $2.71.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.72
    52-week high$5.18-66.8%
    52-week low$1.67+3.0%
    50-day average$1.99-13.8%
    200-day average$2.71-36.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 66.5%.

    MeasureValue
    1-year beta0.95
    Largest fall, 1 year-66.5%
    Largest fall, 3 years-66.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GRCE

    What is GRCE's 1-year price change?

    Grace Therapeutics's price fell 43.8% over the past 12 months. With dividends included, the 12-month total return was -43.8%.

    What is GRCE's 52-week high and low?

    Grace Therapeutics's 52-week high is $5.18 and its 52-week low is $1.67. Its latest price of $1.72 on Nov 17, 2026 is 66.8% below the high.

    What is GRCE's beta?

    Grace Therapeutics's 1-year beta against the S&P 500 is 0.95, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 66.5%.

    Is the GRCE chart free?

    Yes. Advanced Charting for GRCE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.